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Abstract 
Ayurveda is a major traditional system of Indian medicine that is still being successfully used in 
many countries. It advocates the use of both herbal and metallic preparations, in which herbs are 
deliberately combined with metals, minerals and gems. This study is aimed to identify possible 
risks associated to the presence of toxic elements in ayurvedic formulations. We determined the 
concentrations of 25 elements (Al, As, Ag, Au, Ba, Ca, Cd, Co, Cr, Cu, Fe, Hg, K, Mg, Mn, Na, 
Ni, P, Pb, Pd, Pt, Sb, Si, Sn and Zn) in 17 ayurvedic products manufactured in India and sold in 
different distribution channels: Indian ayurvedic medical shops, an Italian pharmacy and on the 
Internet. After sample mineralization, concentrations were determined by Inductively Coupled 
Plasma-Optical Emission Spectroscopy (ICP-OES). We calculated daily intake of each element 
and compared the obtained concentrations with the maximum tolerable intake levels or 
recommended nutrient amounts. Element content found in the products purchased on the Internet 
and in the Italian pharmacy was lower than the safety limits fixed by the international authorities. 
Five medicines purchased in India contained potentially dangerous amount of As, Cu, Hg, and Pb. 
Metal bioaccessibility was studied by extraction with solutions simulating gastric and intestinal 
fluids. The concentration of As potentially adsorbed during the digestion of two products was 
greater than the maximum admissible daily intake for this element. The obtained results were 
treated with chemometric techniques. 
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1. Introduction 
There are many traditional systems of medicine in the world and each one is associated to a 
particular philosophy and culture. In particular, the ayurvedic system of medicine is the most 
widely practised in the Indian traditional medicine systems. In the last years, it has become 
increasingly popular in North America, Europe and Australia [1], so that ayurvedic formulations 
are available from local chemists, ethnic markets, practitioners, health food stores and Internet [1-
7]. Ayurveda advocates both the use of herbal preparations (kasthausadhi), similar to other 
civilizations of the world, and metal-based preparations (rasausadhi), that are unique in Ayurveda 
and not present elsewhere [8]. In fact, rasa shastra is an ancient Indian practice in which herbs 
are deliberately combined with metals (e.g., mercury, lead, iron, zinc), minerals (e.g., mica) and 
gems (e.g., pearl) [9,10]. The metals and metalloids present in ayurvedic formulations are claimed 
to be detoxified by elaborate processing steps including many cycles of heating and subsequent 
cooling in herbal mixtures and animal products such as cow urine or butter (ghee) [11-14]. 
According to the tradition, these processes would eliminate the harmful effects of metals. Metallic 
herbal preparations offer advantages over plant-based drugs by virtue of their stability over a 
longer period, lower dosage, easy storability and sustained availability [8].  
Furthermore, metals may be accidentally introduced into the herbal medicines: the distribution of 
inorganics in the end-products depends on a number of variables, such as climate, soil 
characteristics, conditions of transport, storage and preparation. 
Generally, lead is widely distributed in spices and herbal plants; cadmium in foods is mostly 
derived from various sources of environmental contamination; high levels of arsenic can be due to 
use of fertilizers and pesticides [15-17]. Additional sources of heavy metal contamination can be 
rainfall, presence of vehicular traffic, use of oil or fossil fuels for heating. Pollution may also 
occur during half- and end-products manufacturing or during storage, by leaching of metals from 
containers [18]. 
Moreover, products sold as medications, whether “conventional” or not, should be licensed by the 
health authorities of each country in which they are marketed, and their quality and contents 
closely controlled [4]. Ayurvedic medicines are marketed as “dietary supplements”, which are 
regulated under a specific legislation for traditional herbal medicines in UE [19]. Traditional 
formulations have some typical characteristics, in particular their long time of employment. For 
this reason the UE established an easy procedure for the license of these products, i.e. it is 
possible to register traditional formulations if they have been used for therapeutic purpose in the 
country of origin for at least thirty years, fifteen of which in UE countries. On September 2004 
the Committee for Herbal Medicinal Products (HMPC) was established at the European 
Medicines Agency with the purpose of preparing a list of admitted formulations and plant-based 
products. However some of these products that do not satisfy the medicine requirements, can be 
marketed as “food” or as “food supplement” [20].  
Also in USA, where ayurvedic formulations are regulated by the Dietary Supplement Health and 
Education Act (DSHEA), no proofs of safety or efficacy are required [9].  
Over recent years, some metallic preparations used in the Indian system of medicine have been 
suspected to be harmful because some cases have been published detailing patients poisoned by 
heavy metals after the ingestion of these remedies [1-3,6-8,21-32]. Recently a study conducted on 
ayurvedic medicines by Harvard Medical School [14] also reported that some of these drugs had 
potentially harmful levels of lead, mercury and arsenic. 
Hence it is very interesting to determine the element content in traditional ayurvedic medicines 
available on the market and consequently highlight the possible risks for the costumers. 
Nonetheless, not all the amount of an element present in an ingested product is available for 
absorption by the organism; for this reason the knowledge of the total concentration is not 
sufficient to assess its potential harmful effects, but it is important to value the amount of each 
element potentially assimilated after ingestion. It is quite difficult to determine this parameter 
experimentally, since it would require expensive and ethically troublesome in vivo experiments, 
but it is possible make an in vitro estimation by measuring the bioaccessibility of metals and 
metalloids. Bioaccessibility has been defined as the fraction of a compound that is released from 
its matrix in the gastrointestinal tract, and thus becomes available for intestinal absorption [33]. 
Several in vitro approaches have been developed in attempts to mimic the effects of the human 
digestion process. They are commonly described in the scientific literature under the name of 
physiologically-based extraction test (PBET) or, more generally, simulated gastrointestinal 
extraction procedures [34]. These seek to mimic processes that occur in the different areas of the 
human digestive system and they can be applied to value the risk for human health associated to 
the fraction of different substances absorbed during the digestion of different matrices. For 
example these types of study have been applied to study the bioaccessibility of lipophilic 
nutrients, nutrients, polyphenols and metals from foods and medicines and sediment [33,35-38]. 
In this study we assessed the levels of Al, Ag, Au, As, Ba, Ca, Cd, Co, Cr, Cu, Fe, Hg, K, Mg, 
Mn, Na, Ni, P, Pb, Pd, Pt, Sb, Si, Sn and Zn in seventeen ayurvedic formulations purchased from 
different distribution channels: 7 from medical shops in India, 5 on the Internet, and 5 in an Italian 
pharmacy, to compare the safety of products from different sources. 
We focused our attention on the potentially toxic elements such as As, Cd, Pb and noble metals to 
identify the traditional Indian ayurvedic medicines that were intentionally added with high 
concentrations of such elements and investigate the possible risks for health due to their 
consumption. We considered also macro- (e.g. Ca, Mg, Na, K, P) and micro- nutrients (e.g. Cr, 
Fe, Mn, Ni, Sn, Zn,…) to have a complete idea of the medicines inorganic composition.  
In this way, we can verify if there are substantial differences between the samples commercially 
available in India, those available everywhere in the world from the Internet and those admitted 
by the European Legislation.  
Concentrations were determined by Inductively Coupled Plasma-Optical Emission Spectroscopy 
(ICP-OES) after sample mineralization in a microwave oven. This technique is largely used for 
the determination of metal content in ayurvedic medicines [4,7,13,32]. The results of the analysis 
are interpreted taking into account the meaning of the traditional names of the medicines. We 
treated the data with chemometric techniques to better understand similarities and differences 
among products and correlations among variables, i.e. the investigated elements, which might be 
more difficult to detect just from the dataset [39,40]. 
The estimated daily intake of each element was compared with reference values [41], considering 
the maximum tolerable intake levels or recommended nutrient amounts issued by national and 
international organizations.  
To evaluate the bioaccessibility of the potentially toxic elements during digestion, we adopted the 
procedure suggested by the American Pharmacopeia, simulating the release of the elements in 
stomach and intestine [42]. To our knowledge, this is the first study in which this approach was 
adopted with ayurvedic medicines. 
 
2. Materials and Methods 
2.1. Samples and Sample Pretreatment 
The ayurvedic formulations analyzed were purchased from different commercial channels. 
Products A, B, C, D, E, F and G were purchased in India: A, B, C, D, E and F from a medical 
shop in Chennay city (Tamil Nadu, South-East of India), while sample G in a village in Rajasthan 
region (North-West of India) by Italian tourists; samples H, I, J, K and L from the Internet 
website of an ayurvedic formulations producer; samples M, N, O, P, Q were bought in an Italian 
pharmacy in Torino (Piedmont region). The criterion of choice was the Indian origin of the raw 
materials used for the preparation of the medicines. 
The names of the products, the ingredients declared on the label and the aspect of formulations 
are summarized in Table 1. The meaning of some Indian terms is explained in “Results and 
discussion” section. 
The purchased samples appeared as powder (8 samples), tablet (8) or paste (1). The tablets were 
ground in a mortar in order to obtain powdered samples. The powders and the paste were 
analysed without any pretreatment. 
 
2.2 Apparatus and reagents 
Sample dissolution was performed in polytetrafluoroethylene (PTFE) bombs, with a Milestone 
MLS-1200 Mega (Milestone, Sorisole, Italy) microwave laboratory unit.  
The cations were determined with a Perkin Elmer Optima 7000 (Perkin Elmer, Norwalk, 
Connecticut, USA) inductively coupled plasma-optical emission spectrometer (ICP-OES). 
Standard metal solutions were prepared from concentrated stock solutions (Merck Titrisol or 
Sigma Aldrich). 
High purity water (HPW) produced with Millipore Milli-Q system was used throughout. The 
reagents adopted were of analytical grade.  
The gastric juice was prepared dissolving 2.0 g of NaCl and 3.2 g of pepsin (3200-4500 UI/mg) in 
7.0 mL of HCl. The solution was diluted to 1000 mL with HPW; the final pH is 1.2. 
The intestinal medium was obtained dissolving 6.8 g of KH2PO4 in 250 mL of HPW; then 77.0 
mL of 0.2 N NaOH and 10 g of pancreatin (protease 1.5 UI/mg; amylase 24.2 UI/mg and lipase 
21.7 UI/mg) and 500 ml of HPW were added; finally pH was adjusted to 6.8 with the aid of 0.2 N 
NaOH or 0.2 N HCl and the solution was diluted to 1000 mL with HPW.  
 
2.3 Procedures 
2.2. 1. Dissolution and analysis for total element content 
Acid digestion in microwave oven was adopted to dissolve the samples. Aliquots of 200 mg were 
treated with 3 mL of 65 % HNO3 and 3 mL of 30 % H2O2 in PTFE bombs. Six heating steps at a 
power of 250 (1 min), 0 (2 min), 200 (5 min), 350 (5 min), 550 (5 min), 250 W (5 min) 
respectively, followed by a ventilation step for 10 min, were applied. The resulting solutions were 
filtered on Whatman 5 filters and then diluted to 50 mL with HPW. The solutions were analysed by 
ICP-OES.  
In order to check the accuracy of the experimental procedure, two quality control procedures were 
adopted. Firstly, synthetic solutions consisting of aliquots of sample blank added with known 
concentrations of all the considered analytes were prepared in the bombs of the digestion system 
and treated following the same procedure as for the samples. The final concentration of the 
analytes was 1 mg/L. Then, a Certified Reference Material (CRM), namely Tomato Leaves SRM 
1573a, supplied by the National Institute of Standards and Technology (NIST), was analyzed to 
value the effect of a vegetal matrix on element determination. This CRM contains certified 
concentrations of Ba, Ca, Cd, Co, Cr, Cu, Fe, K, Mg, Mn, Na, Ni, P, Sb, Se and Zn  
Initially, a semiquantitative analysis was conducted on the sample solutions to value the 
concentration levels of the above mentioned elements. Some elements, namely Ag, Au, Cd, Co 
and Sb, were found to be below the detection limits, so 20 analytes with concentration higher than 
the detection limit in most of the samples, or for a group of them, were subjected to quantitative 
analysis.  
Taking into account the results of a preliminary semiquantitative analysis, the concentrations of 
all the analytes in the products from Internet and the pharmacy were determined without any 
dilution, while the quantification of As, Ca, Cu, Fe, Hg, K, P, Pb and Sb in some Indian medicine 
required a 100 (or 1000 in few cases) -fold dilution of the sample solutions. Aliquots of each 
sample solution were diluted with HPW to different dilution levels suitable for the determination 
of the different analytes. The calibrations were performed with standard solutions prepared in 
aliquots of sample blanks diluted in the same ratios as the sample solutions. Standard solutions 
were periodically analyzed and their signals were used to correct the sample signals for drift of 
instrumental sensitivity. 
The limits of detection (LoD) and quantification (LoQ) were estimated as three and ten times the 
standard deviation of the blank respectively. 
 
2.3.2. Study of bioaccessibility  
The efficacy of the extraction of gastric and intestinal media after the same contact time with the 
sample was valued: 200 mg of sample were put in contact with 25 mL of each extractant for 2 h 
maintaining the solutions at the temperature of 37 °C and shaking periodically to mimic peristaltic 
motions of stomach and intestine. 
In a separate experiment, each solution was left in contact for the time suggested by the 
Pharmacopeia [40]: 2h and 6h for gastric and intestinal media respectively. After extraction the 
suspensions were centrifuged at 4000 rpm for 10 minutes. The solutions were filtered on 
Whatman 5 filters.  
All experiments were performed in triplicate. 
 
2.3.3 Chemometric data processing 
A chemometric analysis of the experimental results was performed by Principal Component 
Analysis (PCA), Hierarchical Cluster Analysis (HCA) and Factorial Discriminant Analysis (FDA) 
with the aid of XLSTAT 4.4 software package, used as a Microsoft Excel plug-in. Unscrambler X 
10:2 software package was used for data preprocessing and for some tests by Discriminant 
Analysis. 
The values below detection limit were substituted with a random number between zero and that 
limit. The data were preprocessed by column standardization, i.e. by mean-centering (for each 
variable) and dividing by the corresponding standard deviation.  
PCA is the multivariate technique most extensively used for processing the results of single and 
sequential extractions. This happens because it is relatively easy to apply, using the commercial 
software packages, the interpretation of the data is relatively simple and provide useful 
information. 
PCA is an unsupervised pattern recognition technique, i.e. a technique for classifying objects into 
classes that are not established a priori. It is based on variable reduction through the calculation of 
the so-called principal components (also named “factors” or “latent variables”), which are linear 
combinations of the original variables. The first two PCs were considered in PCA. The 
interpretation of the loading plots was aided by the examination of the Pearson's correlation 
matrix (not reported).  
The aim of cluster analysis is grouping samples or variables; the most frequently used form of 
cluster analysis is HCA. It is an unsupervised pattern recognition technique, in which the clusters 
are formed during the calculation and their number is not decided a priori. The groups are 
obtained stepwise with an agglomerative (starting from single objects and joining them in 
successively larger groups) or divisive (starting from one cluster comprising all objects and 
dividing it into successively smaller and more homogeneous clusters) approach. The clusters are 
formed during the calculation and their number is not decided a priori. HCA was carried out using 
the Euclidean distance and Ward's agglomeration method; the results were reported in a 
dendrogram. 
Linear discriminant analysis (LDA) is a supervised pattern recognition technique, in which 
objects are grouped in classes established by the researcher a priori. It is based on the calculation 
of new variables, called discriminant functions, obtained from linear combinations of the original 
variables. Such linear combinations are derived so as to best indicate the differences between the 
classes in contrast with the variance within the classes [39,40]. 
 
3. Results and discussion 
3.1. Analytical approach 
To verify the accuracy of both digestion and analysis procedures, the concentrations of the 
considered analytes in synthetic solutions a were preliminarily determined and the concentrations 
found were compared with the expected ones: the recoveries obtained were in the range 93 (for P) 
÷ 101 (for Cu) % for all the considered elements, as reported in Table 2; this table also collects 
the LoD and LoQ values. Some of considered analytes, namely Ba, Ca, Cr, Cu, Fe, K, Mg, Mn, 
Na, Ni, P, and Zn were also determined in CRM NIST 1573a: the recoveries range between 85 
and 113% for all considered analytes (Table 2). 
Those results can be considered satisfactory in view of the concentrations involved, so ayurvedic 
drugs were analysed following the same procedure. Unfortunately, the commercially available 
plant based-CRMs contain some elements, such as As, Hg, Pd and Pt in concentration lower that 
the ICP-OES detection limits or are not certified for other elements, as Pd, Pt and Sn. For these 
reasons we periodically checked the goodness of our procedures also with other CRMs (e.g. BCR 
279, BCR 176) and with commercially available Multi-Element Standards for ICP. The recovery 
obtained are generally on the order of ± 15 % for all elements in a range of concentration of 1-100 
mg/L. The uncertainty of the experimental results, evaluated from the standard deviation 
estimates, ranges between 0.5 (Na) and 6.0 (Cu)%.  
 
3.2 Total element content 
Total element contents in the different batches of samples (purchased in India, on the Internet and 
in an Italian pharmacy) will be discussed separately and then compared (paragraph 3.1.4). 
The concentrations of Ag, Au, Cd, Sb are lower than the LoQ in all investigated samples.  
 
3.2.1 Samples from India 
Medicines purchased in India were bought in a traditional Indian medical shop in Chennay city 
(samples A, B, C, D, E and F) and in a village in Rajastan region (G).   
These products belong to the group of ayurvedic drugs called rasausadhi: they are traditional 
multi-ingredients formulations containing herbs and minerals.  
Part of the name of rasausadhi ayurvedic medicines is traditionally referred to the type or to the 
aspect of the preparation: for example “bhasma” means that the formulations contain incinerated 
metals or minerals; “sinduram” that the drugs are prepared by sublimation; “parpam” that they are 
powders, “chenduram” that they are nano-sized particles powders.  
Product G contains “Guggulu” that is “commiphora mukul”, one of the most largely used plants in 
Indian medicine, generally present in the formulations in combination with several other herbs to 
enhance its effects. There are different preparations of “guggulu-based medicines”, namely 
mineral-herbal and herbal only. In sample G the term “yograj” means “formulation of the king” 
denoting that metals have been added during the preparations to increase the effect of the 
medicine, as indicated by the superlative “maha”. 
The obtained results are reported in Table 3. 
We can see a great elemental composition variability among the formulations that reflects the 
high variability of the ingredients adopted. Some elements that are present in trace levels in some 
drugs show very high concentration in others. 
Aluminum, Ca, Fe, Hg, K, Mg, Na, Pb, Si and Zn are the most abundant elements in the group of 
ayurvedic formulations purchased in India: they are present at concentrations greater than 100 
mg/kg in most of these products. Al, Ca, Fe, K, Mg, Na, Si, and Zn are nutrients for humans 
and/or for plants and can derive from natural sources: for instance, the natural herbals 
composition is conditioned by characteristics of the soil and by the water with which the herbs 
were in contact during their growth. Different considerations have to be made for Hg and Pb that 
stand out among the elements with highest concentration. Five samples contain very high level of 
mercury (from 100 to 50,000 mg/kg). Four drugs contain Pb in concentrations greater than 100 
mg, and in one sample the concentration reaches 1.3x105 mg/kg. 
Arsenic concentrations are lower than the LoQ in two products, at mg/kg level in other two, while 
reach g/kg amounts in the other ones. 
Copper shows a high concentration (1.9 and 2.5x10
2
 mg/kg) in two samples and a very high 
content (4.5x10
5 
mg/kg) in another sample. 
Also Pd and Sn, generally absent or present in low concentrations respectively, are contained with 
high concentration in one sample. 
These results reflect the fact that metals and metalloids are intentionally added to some ayurvedic 
formulations to improve the therapeutic effect of the medicine, according to tradition. 
In some cases we obtained very high standard deviations: this is caused by the heterogeneity of 
the materials present in each sample, even if the drugs were grounded in very fine powder. 
For rasausadhi medicines, the high content of some elements, in particular of potentially toxic 
ones, could have been predicted from the names of the formulations: 
Sample A shows high Ca content due to the presence of a shell (“suththi seitha kadal 
sangu”) and CaO (“kilinchal chunnambu”) as ingredients; this formulation also presents 
high concentration of Na (probably derived from the NaCl deposited on the shell) and Zn. 
Sample B (“ekaguna sindura” or “rasa sindura”) contains lower amounts of elements in 
comparison with the others, with the only exceptions of Hg and Pd. “Rasa” means Hg, 
showing that it was intentionally added.  
Samples C and F, both named “thalaka or talaka” that means orpiment (As2S3), present 
high concentrations of As. With the exception of As content, these two products have 
different composition. In particular sample C shows a higher amount of Hg. 
Sample D, called “thambira parpam” (from “tambra”= Cu) contains a high concentration 
of Cu. This drug is also characterized by high concentrations of Fe (3.0x10
4
 mg/kg) and 
Pd (1.2x10
2
 mg/kg), which is present at levels lower than the LoQ in all the other drugs. 
The high content of Pd cannot be connected to the drug name, but the addition of noble 
metals it is a typical practice of “rasa sastra”. 
Sample E is named “vel vanga parpam”: “vanga” means Sn, whose content in this 
formulation is 25.5 mg/kg; anyway other samples (D and G) contain higher concentrations 
of this element. 
Sample G contains a lot of herbs, as listed in Table 1. However, this medicine contains 
also Sn (“vanga bhasma”), Ag (“raupya bhasma”), Pb (“naga bhasma”), Fe (“loha 
bhasma”), mica (“abhrak bhasma”), rust (“mandura bhasma”) HgS (“rasa sindur”) and 
auxiliary exipients (“shesh”). This composition is well represented by the results obtained, 
in particular sample G contains the maximum amount of Pb (1.3x10
5mg/kg) and a very 
high concentration of Hg (4.8x10
3
 mg/kg). The high concentration of As is not related to 
the drug ingredients. The sample also contains a high level of K, probably deriving from 
the herbs adopted. 
 
3.2.2 Samples from the Internet 
The samples purchased on the Internet belong to the ayurvedic formulations called kasthausadhi, 
that is they only contain herbs. They are declared as “metal free” by the producer on the web site 
and the ingredients are declared to have Indian origin. All the medicines are multi-herbs products, 
with the only exception of sample K, that contains only Aloe vera (for this medicine the 
composition is not reported on the label but only on the Internet site).  
Also for these samples part of the name defines the aspect of the preparations according to the 
Indian tradition: the words “vati”, “podi” and prash” mean “tablets”, “powder” and “paste” 
respectively. But the characteristic of the kasthausadhi formulations is that they are named after 
their benefits or action towards the body parts or disease and not after their ingredients. For 
example “vaira” (=diamond) means that the drug enhances sturdiness; “shanti” (=peaceful) that it 
induces relax; “niragada” is a Sanskrit name and we were not able to translate it; “kumari” 
(=young lady) indicates that the medicine is supposed to help to remain young.  
The elements showing the highest content in the medicines purchased on the Internet are Al, Ca, 
Fe, K, Mg, Na; P and Si. 
The presence of Si and Mg are declared on the label for products H, I and J and derives from the 
excipients contained in them, namely silica and magnesium stereate; the high concentrations of P 
and K derive from the plants present as major constituents in these formulations.  
Arsenic, Cr, Hg and Pb are always present at concentrations lower than 5 mg/kg. 
The amounts of Pt and Pd are not reported because they are always below the LoQs.  
 
3.2.3 Samples from Italian pharmacy 
The drugs purchased from a pharmacy in Torino belong to the kasthausadhi group, with the 
exception of sample P in which also minerals are present. Also in this case, we selected 
commercial products containing ingredients coming from India. The total concentrations are 
reported in Table 5. 
 
All the selected products are well known traditional ayurvedic formulations.  
In sample M “nidra” means meditation and “shanti” peaceful; in sample O “rakta” reinforces 
“shanti”. Both these products are indicated to reduce blood pressure.  
Unlike sample G, purchased in India (paragraph 1.1.1), sample N, “kaishor guggulu”, is a type of 
guggul preparation that belongs the kasthausadhi family since it is only herbal-composed. It is 
traditionally used to treat a great variety of problems (from weak digestion to cancer).  
As to sample P, “chandraprabha” means moonlight, to define its effect on the health problems 
influenced by moon cycles. 
In sample Q, “praval moti” means “refresh”: it is a strong mineral salts supplement used to 
balance depletion of bodily fluids. 
The medicines purchased in Torino present great amounts of Ca, K, Mg, Na, Fe, Si and P. As 
observed above, the high concentrations of K and P come from the plants adopted for these 
preparations. The high concentration of Ca observed in sample Q derives from the presence of 
calcined coral and pearl in the product. 
The concentrations of As, Hg, Pd and Zn were lower than the instrumental LoQ in all samples 
with the only exception of sample M, in which As was detected at very low level. In all the 
products Cu, Cr, Ni and Pb show concentrations lower than 5 mg/kg.  
The amounts of Hg, Pd, Pt and Zn are not reported because they are always below the LoQs.  
 
3.2.4 Comparison among the different groups of medicines 
Figure 1 shows the percentages of samples, divided for each group, containing element 
concentrations higher than 100 mg/kg. 
Aluminum, Ca, Fe, K, Mg, Na, P and Si are generally the most abundant elements in all the 
medicines, showing no difference between rasausadhi and kasthausadhi drugs. The concentration 
level of Mn is randomly higher than 100 mg/kg in the three groups of drugs. These elements 
derive from the vegetal components of the formulations or from the excipients. 
The presence of As, Cu, Hg, Pb, Pd, Sn and Zn at high concentration levels is a characteristic of 
the rasaushadi preparations. 
The obtained results show great differences between the kasthausadhi and rasausadhi drugs: in 
the latter, intentional addition of As, Hg, Pb and noble metals is still adopted, according to the 
tradition. This causes the presence of high concentrations of potentially toxic elements, as 
demonstrated by our measurements. 
We have to underline the important difference between the two “guggulu preparations”, G (“maha 
yograj guggulu”) and N (“kaishor guggulu”). Sample G, purchased in a village in India, contains 
very high amounts of As, Hg and Pb, that are absent in sample N purchased in the Italian 
pharmacy. To avoid health risks, the customers have to be aware of the drug composition that 
they are assuming, since a medicine named after a herbal component can belong to both 
katsausadhi and rahsausadhi. For instance a tourist from a Western country, who usually 
consumes a product in his nation of origin, during a trip to India, might buy a product with a 
similar name, but a different composition, also taking into account that labels may be written in 
foreign languages, with Sanskrit fonts. At the same time, practitioners should have an extensive 
knowledge of ayurvedic medicine tradition and of the feature of each formulation, even in the 
presence of similar names, and indicate the right dosage to avoid health risks.  
 
3.2.5 Chemometric data processing 
PCA and HCA are multivariate techniques that take into account simultaneously the behaviour of 
more variables (in our work the variables are the element concentrations).  
Processing the data on total concentrations of all considered analytes with these techniques, as we 
can see (Figures 2.1 and 3.1) the samples are grouped all together with the exception of 
formulations D and G, the first characterized by high concentrations of Cu, Fe and Pd, and the 
second (the only formulation purchased in an Indian village) containing high levels of Pb, As and 
K. The three groups of medicines (i.e. from India, Italy and Internet) are not separated, probably 
because of the high variability of the compositions of the formulations, even among products 
belonging to the same group, and the presence of a vegetal matrix that characterizes all the 
considered medicines. In order to better investigate the effect of the presence of the herbal matrix 
we treated separately the data on total concentrations of i) the elements that have very high values 
only in the samples purchased in India (As, Cu, Hg, Pb, Pd, Sn and Zn) and of ii) the most 
abundant elements (Al, Ca, Fe, K, Mg, Na, P and Si) (see paragraph 3.1.4). We expected that only 
in the first case the group of rasaushadi medicines would be well separated from the other 
samples, but in both cases we observed a differentiation between the rasausadhi and kasthausadhi 
drugs, with the exception of sample B. In particular, Figure 2.2, reporting PCA for case i), shows 
that all the drugs are grouped together with the exception of nearly all samples purchased in India, 
i.e. A, C, D, E, F and G; instead the score of sample B (characterized by lower amounts of 
considered analytes with the exception of Hg) and the medicines purchased in Internet and in Italy 
are overlapped. An interesting result comes from Figure 2.3, showing PCA for case ii): the scores 
of all the formulations are generally more separated, but also in this case it is possible to 
distinguish the scores of the samples A, C, D, E, F, G which are in the upper area of the plot, 
while the others are in the lower region. 
HCA confirmed these trend: considering all the analytes together, all the samples are mixed, 
while considering cases i) and ii) separately, in Figure 3.2 and 3.3 we observe a more clear 
separation between rasausadhi and kasthausadhi products. We can underline that in the case i) all 
the rasausadhi formulations are grouped with the exception of sample E (instead of the product 
B). 
As to the loadings, the following positive correlations can be observed: Fe and Mn, Zn, Pd and 
Cu; Pb and Sn. Moreover, two negative correlations are present: Ca with K, P and Na; Si with 
Mg. On the other hand, As and Hg have no significant correlations with other elements. The 
observed correlations probably arise from the chemical properties of the elements as well as from 
their sources.  
We also treated the data with Factorial Discriminant Analysis (FDA).  
Unfortunately, Unscrambler X 10:2 software package did not allow us to apply DA to our data, 
because of the limited number of samples in each group. On the other hand, XLStat 4.4 performed 
the calculations even in these conditions, and the results are reported hereafter: anyway, owing to 
the different outputs of the two software packages, such results should be considered as 
approximate. Figure 4 shows that the three groups of ayurvedic products are well separated, in 
particular we can observe a clear separation between rasausadhi and kasthausadhi groups.  
 
3.3. Daily intake and reference values 
One of the major concerns for kashausadhi drugs, is the nature of the source materials. 
Many papers report the determination of As and heavy metal concentrations in different types of 
plants including vegetables, cereals and fruits etc., but less work has been reported on medicinal 
plants [43-47]. Herbal drugs can contain potentially toxic elements deriving from the 
environment, in particular from polluted water, soil and atmospheric particular matter. For 
instance, some areas of India are severely affected by As pollution, since soils and natural waters 
contain high level of this element causing a serious contamination of the cultivars. The safety and 
quality of herbal drugs depend on various factors, and contamination by metals and pesticides 
during any stage of production can occurred. So, it is important to verify the concentrations of 
potentially toxic elements both in raw materials and in the end-products, which are used more 
widely in Western countries as compared to crude drugs. 
The daily intake for each considered element upon consumption of ayurvedic medicines was 
calculated taking into account the posology suggested on the package leaflet, when present, or 
indications from literature. As expected from the high variability of the ingredients present in 
these medicines, the intake is different for each sample. These amounts were compared with the 
daily limits suggested by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) for 
a standard human of 60 kg calculated from Provisional Maximum Tolerable Daily Intake 
(PMTDI, mg/bw/d), Provisional Tolerable Weekly Intake (PTWI, mg/ bw/w) and Provisional 
Tolerable Monthly Intake (PMTI mg/bw/m) values, with bw = body weight [41]. 
Table 6 reports the range of estimated daily intake upon consumption of ayurvedic medicines of 
the three considered groups (mg/d, min–max) and the corresponding admissible value for each 
element (referred to an individual of 60 kg). The values for the single medicines are reported in 
the Supplemental data (Appendix A). 
All the elements determined in the formulations sold from the Internet and the Italian pharmacy 
presented concentrations lower than the safety limits for all considered elements. These results 
reflect the good quality of the Indian plants adopted for the preparation of these formulations and 
the lack of contaminations during the manufacturing steps.  
Among the medicines purchased in India, five samples presented concentration levels exceeding 
the maximum daily intake for the following elements: Hg (B: Ekaguna Sindura, 4,94-9,88 mg/ d), 
Hg and As (C: Thalaka Chenduram 19.4 mg/ d for Hg and 2.4x10
-2
 mg/ d for As), Cu (E: Vel 
Vanga Parpam, 22.9-45.8 mg/ d), As (F: Talaka Bhasma 45.2-84.3 mg/ d) and Pb (G: Maha 
Yograj Guggulu 135 mg/ d) (data reported in supplementary material).  
 
3.4 Study of bioaccessibility  
Bioaccessibility studies are carried out in order to estimate the portion of an element, present in 
ingested material (food, medicine,…), which is available for uptake by the organism [47]. 
Since some investigated products revealed a possible toxic level of As, Cu, Hg and Pb, it is 
important to know to what extent such elements can be assimilated, since the total concentrations 
might lead to an overestimation of the real risk for health. For this reason we applied extraction 
procedures simulating the effect of gastric and intestinal juices to samples C, D and F. 
Unfortunately, it was not possible to make these experiments with samples B and G since the 
available amounts of these products were not sufficient for the test. 
The element release in the mouth was not considered, because in literature it is demonstrated that 
saliva has only a negligible effect on the level of mobilization of metal contaminants, since the pH 
of saliva is close to neutral [33]. 
We adopted the procedure suggested by the American Pharmacopeia; like most of the studies on 
bioaccessibility; this procedure considers the addition of enzymes to the extractant solutions to 
mimic the natural fluids [34]. For the sake of completeness, we determined the release of all the 
investigated elements, with the exception of K, Na and P, which were present in the adopted 
reagents. 
Initially, we assessed the capacity of extraction of the two considered media (gastric and 
intestinal) using the same contact time (2h). Then, we left each sample in contact with the 
solutions for the time indicated in the methods, 2 and 6 h for gastric and intestinal media 
respectively. No differences were observed in the percentages of extraction obtained at different 
times for intestinal juice, demonstrating that after 2h the extraction in the intestinal solution can 
be considered complete.  
Table 7 reports the results obtained treating samples C, D and F with the two considered media. In 
the table we also show the daily intake calculated from the total amount of each element released 
during a hypothetic digestion and the maximum posology for each sample. 
Generally, the release of most of the analytes in the gastric medium was lower than that in the 
intestinal one. The acid pH of the stomach juice permits a greater dissolution of the hydroxides, 
oxides, other salts (such as sulfides) and organic species (complexes between elements and the 
organic components present in the plants) of the elements contained in the medicines. In 
particular, Al, Cr, Cu, Fe, Mn, Ni, Pb, Si and Zn present higher percentages of extraction in the 
gastric juice than in the intestinal one for all the considered samples, with the only exception of 
Cu and Pb in sample C that show similar release in both media. Ca and Mg are quantitatively 
extracted into intestinal media from samples C and F.   
The leachability of As is similar in both media; Hg is always present in solution in concentration 
lower than the instrumental LoQ.  
We observed a great variability in the extracted percentages of the same analyte from the different 
samples: the release of an element depends on the form in which it is present in the considered 
material, which determines how strongly it is bound to inorganic or organic components 
contained in the matrix. The great differences of elements behavior in the samples reflects the 
great assortment of adopted ingredients in the ayurvedic formulations. 
For example, As is present in samples C and F as orpiment (thalaka): this mineral is insoluble in 
water, in acid and alkaline media and in fact a low release of As is observed from these drugs. On 
the contrary As is quantitatively extracted from sample D in both media, suggesting that it is not 
strongly bound to the medicine matrix. Its total concentration in this sample is low and we were 
not able to identify a possible source. These considerations lead us to suppose that a pollution of 
the drug took place, presumably during the growing, irrigation and/or manufacturing steps. 
From the comparison between the maximum daily intake and reference admissible values, we can 
observe possible risks associated to the consumption of samples C and F, even if the percentages 
of release of As are low. The concentration of As in the considered “talaka formulations” is so 
high that even a very low release is sufficient to exceed JECFA limits; the maximum acceptable 
percentage of release would be 0.67 % for sample C and 0.31 % for sample F.  
The amount of Cu released from sample D (0.51 mg/d) is much lower than the maximum 
admissible value (4.3 mg/d), so no risks seem to be associated to the consumption of this drug.  
As expected, the total amounts potentially released during digestion for all the other analytes were 
lower than daily limits. 
 
4. Conclusions 
The great variability in inorganic compositions of the investigated ayurvedic medicines derives 
from the great assortment of the ingredients adopted. 
In particular, the high content of As and metals as Cu, Hg and Pb in the drugs purchased in India 
is mainly caused by the intentional addition of these elements during the medicine preparation 
following the rasa shastra tradition.  
To be marketed in Western countries, ayurvedic medicines have to be declared “metal free”. For 
this reason it is possible to purchase only kasthausadhi products. Drugs sold in pharmacies assure 
more safety for the customers in comparison to other market channels. On-line shopping might 
present more risks associated to the difficulty to control the quality of the available products. For 
this reason we checked and compared metal content in formulations purchased on the Internet and 
in pharmacies: no remarkable features were observed for the products bought in our study from 
these two commercial channels. The inorganic contents of the medicines purchased online were 
lower than the maximum admissible level so there are no risks from the point view of the 
presence of metals, in the investigated products. It must be pointed out that we did not analyze the 
organic components of the medicines, so we cannot make any statement on the overall quality of 
the formulations. 
It is interesting to note that the names of ayurvedic formulations are often indicative of their main 
component, or of the procedure used for their preparation. On the other hand, two drugs with a 
similar name may have a different content of potentially toxic elements. 
The chemometric data processing showed that the medicines purchased in India were 
differentiated from the other products, owing to the higher concentrations of potentially toxic 
elements. 
Bioaccessibility studies showed that the amount of metals actually released during the ingestion is 
lower than the total amount, but in some cases is still higher than the maximum admissible level. 
Due to the great compositional differences observed among the ayurvedic formulations, our study 
underlines the importance: i) to know very well the traditions according to which the formulation 
are prepared; ii) to understand and to respect the dosage of assumption, in particular avoiding the 
unlabeled products, and translating the leaflet if written in foreign languages; iii) to consume 
medicines only under medical counsel and iv) to purchase them from controlled commercial 
channels. 
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